KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nektar Therapeutics (NKTR) Shares Outstanding (Diluted Average): 2016-2024

Historic Shares Outstanding (Diluted Average) for Nektar Therapeutics (NKTR) over the last 9 years, with Dec 2024 value amounting to $205.7 million.

  • Nektar Therapeutics' Shares Outstanding (Diluted Average) rose 35.82% to $18.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.9 million, marking a year-over-year increase of 35.82%. This contributed to the annual value of $205.7 million for FY2024, which is 8.24% up from last year.
  • According to the latest figures from FY2024, Nektar Therapeutics' Shares Outstanding (Diluted Average) is $205.7 million, which was up 8.24% from $190.0 million recorded in FY2023.
  • Nektar Therapeutics' Shares Outstanding (Diluted Average)'s 5-year high stood at $205.7 million during FY2024, with a 5-year trough of $178.6 million in FY2020.
  • In the last 3 years, Nektar Therapeutics' Shares Outstanding (Diluted Average) had a median value of $190.0 million in 2023 and averaged $194.3 million.
  • Data for Nektar Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY grew of 8.24% (in 2024) over the last 5 years.
  • Over the past 5 years, Nektar Therapeutics' Shares Outstanding (Diluted Average) (Yearly) stood at $178.6 million in 2020, then increased by 2.64% to $183.3 million in 2021, then rose by 2.09% to $187.1 million in 2022, then grew by 1.53% to $190.0 million in 2023, then grew by 8.24% to $205.7 million in 2024.